XML 82 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 29, 2019
Dec. 30, 2018
Current assets:    
Cash and cash equivalents $ 191,877 $ 163,111
Accounts receivable, net 725,184 632,669
Inventories 356,937 338,347
Other current assets 100,381 100,507
Total current assets 1,374,379 1,234,634
Property, plant and equipment, net 318,223 318,590
Operating Lease, Right-of-Use Asset 167,276 0
Intangible assets, net 1,283,286 1,199,667
Goodwill 3,111,227 2,952,608
Other assets, net 284,173 270,023
Total assets 6,538,564 5,975,522
Current liabilities:    
Current portion of long-term debt 9,974 14,856
Accounts payable 235,855 220,949
Accrued restructuring and contract termination costs 11,559 4,834
Accrued expenses and other current liabilities 503,332 528,827
Current liabilities of discontinued operations 2,112 2,165
Total current liabilities 762,832 771,631
Long-term debt 2,064,041 1,876,624
Long-term liabilities 751,468 742,312
Operating Lease, Liability, Noncurrent 146,399 0
Total liabilities 3,724,740 3,390,567
Commitments and contingencies (see Notes 14 and 17)
Stockholders' equity:    
Preferred stock—$1 par value per share, authorized 1,000,000 shares; none issued or outstanding 0 0
Common stock—$1 par value per share, authorized 300,000,000 shares; issued and outstanding 111,140,000 and 110,597,000 shares at December 29, 2019 and December 30, 2018, respectively 111,140 110,597
Capital in excess of par value 90,357 48,772
Retained earnings 2,811,973 2,602,067
Accumulated other comprehensive loss (199,646) (176,481)
Total stockholders' equity 2,813,824 2,584,955
Total liabilities and stockholders' equity $ 6,538,564 $ 5,975,522